| Literature DB >> 31737258 |
Judith Ter Schure1, Peter Grünwald1.
Abstract
Studies accumulate over time and meta-analyses are mainly retrospective. These two characteristics introduce dependencies between the analysis time, at which a series of studies is up for meta-analysis, and results within the series. Dependencies introduce bias - Accumulation Bias - and invalidate the sampling distribution assumed for p-value tests, thus inflating type-I errors. But dependencies are also inevitable, since for science to accumulate efficiently, new research needs to be informed by past results. Here, we investigate various ways in which time influences error control in meta-analysis testing. We introduce an Accumulation Bias Framework that allows us to model a wide variety of practically occurring dependencies including study series accumulation, meta-analysis timing, and approaches to multiple testing in living systematic reviews. The strength of this framework is that it shows how all dependencies affect p-value-based tests in a similar manner. This leads to two main conclusions. First, Accumulation Bias is inevitable, and even if it can be approximated and accounted for, no valid p-value tests can be constructed. Second, tests based on likelihood ratios withstand Accumulation Bias: they provide bounds on error probabilities that remain valid despite the bias. We leave the reader with a choice between two proposals to consider time in error control: either treat individual (primary) studies and meta-analyses as two separate worlds - each with their own timing - or integrate individual studies in the meta-analysis world. Taking up likelihood ratios in either approach allows for valid tests that relate well to the accumulating nature of scientific knowledge. Likelihood ratios can be interpreted as betting profits, earned in previous studies and invested in new ones, while the meta-analyst is allowed to cash out at any time and advice against future studies. Copyright:Entities:
Keywords: accumulation bias; cumulative; evidence-based research; likelihood ratio; living systematic reviews; meta-analysis; research waste; sequential
Mesh:
Year: 2019 PMID: 31737258 PMCID: PMC6808047 DOI: 10.12688/f1000research.19375.1
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Figure 1.Sampling distributions of meta-analysis -scores under the null hypothesis in the Gold Rush scenario, under the equal study size assumption, with and values for , , and from Eq. (3.2). is as defined in Eq. (3.1b). the standard normal density function shifted by , with shorthand for . See Appendix A.7 for the code that produces the simulation and this figure.
Expected -scores under the null hypothesis in the Gold Rush scenario, under the equal study size assumption, calculated using Eq. (3.4b) with and values for , , and from Eq. (3.2). is as defined in Eq. (3.1b). See Appendix A.7 for the code that was used to calculate these values.
| Number of studies | |||
|---|---|---|---|
| 1 | 0.000 | 0.487 | 0.000 |
| 2 | 0.000 | 1.328 | 0.344 |
| 3 | 0.000 | 1.328 | 1.048 |
| 4 | 0.000 | 1.328 | 1.572 |
| 5 | 0.000 | 1.328 | 2.000 |
| 6 | 0.000 | 1.328 | 2.368 |
| 7 | 0.000 | 1.328 | 2.695 |
| 8 | 0.000 | 1.328 | 2.990 |
| 9 | 0.000 | 1.328 | 3.262 |
| 10 | 0.000 | 1.328 | 3.515 |
Inflated type-I error rates for tests affected by bias only and tests affected by bias as well as impaired sampling distribution. Simulated values are under the null hypothesis in the Gold Rush scenario, under the equal study size assumption, with and values for , , and from Eq. (3.2). See Appendix A.7 for the code that produces the simulation and this table.
| Number of studies | ||
|---|---|---|
| 2 | 0.06 | 0.10 |
| 3 | 0.18 | 0.23 |
| 4 | 0.35 | 0.40 |
| 5 | 0.52 | 0.53 |
Possible 2001 state of a database of study series per topic, visualizing what study series are taken into account in the two approaches to error control: conditional on time (blue and grey) and surviving over time (orange).
| Topics | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | … | 9 998 | 9 999 | 10 000 | ||
| Study series size ( | |||||||||||||||